Record stringlengths 1 197k |
|---|
<|newrecord|> nctId: NCT06331806 id: IEO 398 briefTitle: Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity overallStatus: RECRUITING date: 2018-02-22 date: 2024-12-31 date: 2024-12-31 date: 2024-03-26 date: 2024-03-26 name: European Institute of Oncology class: OTHER briefSummary:... |
<|newrecord|> nctId: NCT06331793 id: IEO 1849 briefTitle: Pulsed Electromagnetic Fields for Analgesia Post Mastectomy acronym: Algocare overallStatus: RECRUITING date: 2023-05-09 date: 2024-12-31 date: 2024-12-31 date: 2024-03-26 date: 2024-03-26 name: European Institute of Oncology class: OTHER briefSummary: Study aim... |
<|newrecord|> nctId: NCT06331780 id: WS10370 id: 2023-A02153-42 type: OTHER domain: ANSM (France) briefTitle: Refractive Status and Accommodation Response Under Different Experimental Conditions. overallStatus: RECRUITING date: 2024-02-22 date: 2024-07-31 date: 2024-12-31 date: 2024-03-26 date: 2024-03-26 name: Essilor... |
<|newrecord|> nctId: NCT06331767 id: 2024P000654 briefTitle: Development of a Multilevel HIV Prevention Intervention for the Emergency Department acronym: mSYNC overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2029-04 date: 2029-04 date: 2024-03-26 date: 2024-03-26 name: Brigham and Women's Hospital class: OTHER b... |
<|newrecord|> nctId: NCT06331754 id: ATMANHEALTH001 briefTitle: Technology-Enabled Remote Hypertension Management To Advance Health Equity overallStatus: NOT_YET_RECRUITING date: 2024-03-18 date: 2025-09-17 date: 2026-03-17 date: 2024-03-26 date: 2024-03-26 name: Atman Health, Inc class: INDUSTRY briefSummary: The prim... |
<|newrecord|> nctId: NCT06331741 id: 0403 briefTitle: Collagen for Treatment of Musculoskeletal Injuries overallStatus: RECRUITING date: 2024-03-01 date: 2025-03-01 date: 2026-03-01 date: 2024-03-26 date: 2024-03-26 name: I.M. Sechenov First Moscow State Medical University class: OTHER briefSummary: The purpose of the ... |
Evaluation of the clinical efficacy and safety of the use of collagen matrix/membrane in the surgical treatment of the consequences of injuries and diseases of the musculoskeletal system (anterior cruciate ligament tears, rigid first toe) by using IKDC, KOOS, ACLOAS, VAS, AOFAS, SF-36 scales conditions: Anterior Crucia... |
<|newrecord|> nctId: NCT06331728 id: IGNX-T1 briefTitle: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001 overallStatus: NOT_YET_RECRUITING date: 2024-07 date: 2025-08 date: 2025-10 date: 2024-03-26 date: 2024-03-26 name: IgGenix Australia Pty Ltd class: INDUSTRY briefSummary... |
<|newrecord|> nctId: NCT06331715 id: ML1005 briefTitle: Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg overallStatus: NOT_YET_RECRUITING date: 2024-05-06 date: 2024-08-01 date: 2024-08-31 date: 2024-03-26 date: 2024-03-26 name: Megalabs class: INDUSTRY briefSummar... |
<|newrecord|> nctId: NCT06331702 id: CDBJEIV2023001 briefTitle: Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) overallStatus: RECRUITING date: 2024-03-02 date: 2024-09-30 date: 2024-12-31 date: 2024-03-26 date: 2024-03-26 name: Liaoning Chengda Biotechnology CO.... |
<|newrecord|> nctId: NCT06331689 id: HP-epidemıology briefTitle: EPIDEMIOLOGY AND ITS RESULTS IN HIP FRACTURES FOLLOWED IN POSTOPERATIVE INTENSIVE CARE acronym: Hip fractures overallStatus: COMPLETED date: 2021-02-01 date: 2021-04-01 date: 2021-07-01 date: 2024-03-26 date: 2024-03-26 name: Kutahya Health Sciences Unive... |
Participant population/health conditions:Patients over the age of 18 who are hospitalized in the intensive care unit of our hospital after hip fracture operation. conditions: Hip Fracture conditions: Mortality Rate studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 68 type: ACTUAL... |
<|newrecord|> nctId: NCT06331676 id: 69HCL23_1120 id: 2023-A02339-36 type: OTHER domain: ID RCB briefTitle: Developing a Complex ex Vivo Endometrial Tissue Model to Improve Endometriosis Care acronym: OTEndo overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-10 date: 2025-10 date: 2024-03-26 date: 2024-03-26 na... |
There is no cure for endometriosis. Hormonal treatments should be the first line therapy. The benefit-risk ratio of symptomatic treatment with hormone therapy varies greatly from one woman to another. The pathophysiology of endometriosis and the mechanisms of action of these treatments are still poorly understood. This... |
The aim of this project is to develop a complex ex vivo endometrial model recapitulating the organisation and properties of the human endometrium using innovative tissue bioengineering methods. This model will make it possible to develop a pre-clinical approach that predicts individual response to different types of ho... |
<|newrecord|> nctId: NCT06331663 id: KMUHIRB-F(II)-20240055 briefTitle: SPI and Remifentanil in Skull Pin Fixation overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-06-20 date: 2024-06-20 date: 2024-03-26 date: 2024-03-26 name: Kaohsiung Medical University Chung-Ho Memorial Hospital class: OTHER briefSummar... |
Data collection: heart rate, mean blood pressure, Surgical Pleth Index, bispectral Index, pulse pressure variance, systolic pressure variance, concentrations of propofol and remifentanil before 2 mins, during, 5, and 15 mins of skull pin fixation were recorded and analyzed. conditions: Pain, Procedural studyType: INTER... |
<|newrecord|> nctId: NCT06331650 id: CROC202314 briefTitle: A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer overallStatus: RECRUITING date: 2023-08-09 date: 2025-08 date: 2025-10 ... |
<|newrecord|> nctId: NCT06331637 id: 3782 briefTitle: Outcomes of Transanal Tran-section and Single-stapled (TTSS) Ileal Pouch-Anal Anastomosis acronym: TTSS-Pouch overallStatus: NOT_YET_RECRUITING date: 2024-07-31 date: 2026-07-31 date: 2026-12-31 date: 2024-03-26 date: 2024-03-26 name: Istituto Clinico Humanitas clas... |
<|newrecord|> nctId: NCT06331624 id: GRI-0621-IPF-02 briefTitle: Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF overallStatus: RECRUITING date: 2024-03 date: 2025-01 date: 2025-01 date: 2024-03-26 date: 2024-03-26 name: GRI Bio Operations, Inc. class: INDUSTRY briefSummary: ... |
<|newrecord|> nctId: NCT06331611 id: Motor briefTitle: MONITORING NEUROMUSCULAR BLOCK IN PAEDIATRIC ANAESTHESIA acronym: MOTOR overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-12-31 date: 2025-12-31 date: 2024-03-26 date: 2024-03-27 name: Istituto Giannina Gaslini class: OTHER briefSummary: To date there i... |
The main objective of the study is to analyse the incidence of sugammadex use and the total dose/kg, with and without the aid of quantitative neuromuscular monitoring. |
Secondary objectives are: |
* the time required to extubate different patients, |
* the incidence of respiratory complications at extubation, |
* the need to administer additional doses of sugammadex. A prospective RCT. Patients will be divided into two study groups; in the first group, quantitative neuromuscular monitoring based on electromyography (EMG) will be used, while in the second group, the same monitoring will be applied but covered (blinded to the a... |
* Children between 2 months and 6 years |
* Children who will undergo elective non cardiac surgery (maximum two hours of anesthesia time with tracheal intubation receiving a non depolarizing blockade agent), |
* Acquisition of informed consent by a legally recognized representative capable of understanding the document and providing consent on behalf of the participant. |
* Children under 2 months of age or over 12 years of age, |
* Children with an ASA classification \> 3, |
* Presence of neuromuscular disease, channelopathy, or any clinical condition that contraindicates the administration of neuromuscular muscle relaxants, |
* Confirmed or suspected allergy to sugammadex or rocuroniumt, |
* Presence of amputation or limb malformations that make placement of neuromuscular monitoring impossible, |
* Any specific contraindication to any aspect of the protocol. 12 months The randomization process will performed using numbers randomized by a computer-generated random number sequence. The randomization list will be prepared by independent statistician . The subjects will be assigned to the treatment arm in a sequenc... |
One hundred children undergo in the clinically guided group and 100 children in the neuromuscular monitoring groups with the aim to include 200 children in total. |
Demographics and baseline characteristics with mean, median, standard deviation, and range (minimum, maximum) will generated for each arm. Subject disposition, including the number of subjects withdrawn or discontinued from the study, for each arm will summarized. The study will follow the CONSORT guidelines for statis... |
<|newrecord|> nctId: NCT06331598 id: ML43332 id: 2022-003708-33 type: EUDRACT_NUMBER briefTitle: A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI... |
<|newrecord|> nctId: NCT06331585 id: KY-2024004 briefTitle: Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy overallStatus: WITHDRAWN date: 2024-03-18 date: 2025-03-18 date: 2026-03-18 date: 2024-03-26 date: 2024-04-25 name: Hetian District People's Hospit... |
<|newrecord|> nctId: NCT06331572 id: 1stChongqingMU-TRD briefTitle: Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression overallStatus: COMPLETED date: 2021-08-01 date: 2021-10-25 date: 2023-12-20 date: 2024-03-26 date: 2024-03-26 name: First Affiliated Ho... |
<|newrecord|> nctId: NCT06331559 id: SIM0501-101 briefTitle: Study of SIM0501 Alone and in Combination in Patients With Advanced Solid Tumors overallStatus: RECRUITING date: 2024-03-19 date: 2026-06-30 date: 2027-12-31 date: 2024-03-26 date: 2024-04-02 name: Jiangsu Simcere Pharmaceutical Co., Ltd. class: INDUSTRY name... |
<|newrecord|> nctId: NCT06331546 id: IRB300004693 id: R01DK137784 type: NIH link: https://reporter.nih.gov/quickSearch/R01DK137784 briefTitle: Gut Oxalate Absorption in Calcium Oxalate Stone Disease overallStatus: RECRUITING date: 2024-05-01 date: 2030-12-31 date: 2031-12-31 date: 2024-03-26 date: 2024-04-03 name: Univ... |
The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. |
Participants will |
* ingest fixed diets containing low and moderately high amounts of oxalate for 5 days at a time |
* ingest a soluble form of oxalate and sugar preparations to test gut permeability |
* collect urine, blood, stool and breath sample during the fixed diets and the soluble oxalate test conditions: Kidney Stone conditions: Kidney Calculi conditions: Urolithiasis conditions: Urolithiasis, Calcium Oxalate conditions: Nephrolithiasis conditions: Nephrolithiasis, Calcium Oxalate conditions: Oxalate Urolithi... |
<|newrecord|> nctId: NCT06331533 id: IstanbulTRH1 briefTitle: Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea overallStatus: COMPLETED date: 2022-11-01 date: 2023-05-01 date: 2023-06-01 date: 2024-03-26 date: 2024-03-29 name: Istanbul Training and Research Hospital class: OTHER_GOV briefSummary: Invest... |
<|newrecord|> nctId: NCT06331520 id: Desineo briefTitle: NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-05-01 date: 2026-05-01 date: 2024-03-26 date: 2024-03-26 name: Fudan University class: OTH... |
<|newrecord|> nctId: NCT06331507 id: HUM00176904 briefTitle: Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch overallStatus: TERMINATED date: 2021-09-02 date: 2023-06-29 date: 2023-06-29 date: 2024-03-26 date: 2024-03-26 name: University of Michigan class: OTHER na... |
<|newrecord|> nctId: NCT06331494 id: SICAS briefTitle: Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery acronym: SICAS overallStatus: NOT_YET_RECRUITING date: 2024-03-15 date: 2026-05-31 date: 2026-08-31 date: 2024-03-26 date: 2024-03-26 name: First Affiliated Hospital, Sun Y... |
<|newrecord|> nctId: NCT06331481 id: 0005-22-HYMC briefTitle: The Effect of Over Weight on Oocytes Quality in IVF Patients acronym: IVF overallStatus: ACTIVE_NOT_RECRUITING date: 2022-02-01 date: 2023-12-31 date: 2024-07 date: 2024-03-26 date: 2024-03-26 name: Hillel Yaffe Medical Center class: OTHER_GOV briefSummary: ... |
This study is prospective observational cohort study performed between February 2022 until June 2022 in a single university-affiliated hospital. conditions: IVF conditions: Overweight studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 50 type: ACTUAL name: Fullicular fluid for cytol... |
<|newrecord|> nctId: NCT06331468 id: MCC-23-GYN-10 briefTitle: Hypofractionated Radiochemotherapy overallStatus: NOT_YET_RECRUITING date: 2024-06-01 date: 2026-08-01 date: 2028-08-01 date: 2024-03-26 date: 2024-03-26 name: Denise Fabian class: OTHER briefSummary: The goal of this clinical trial is to investigate the us... |
* What is the MRI-assessed rate of response at 1-month and 3-months post-treatment? |
* What is the safety and tolerability of cisplatin-based hypofractionated pelvic Intensity Modulated Radiation Therapy (IMRT) followed by brachytherapy? |
* What is the median progression-free survival and overall survival at 1 and 2 years for patients who undergo cisplatin-based hypofractionated pelvic IMRT? |
* What is the proportion of patients who complete the treatment in prescribed timeframe? |
* What the levels of cervix cancer circulating tumor cells pretherapy and after treatment? |
To confirm eligibility, within four weeks prior to study enrollment, all patients will undergo the following: |
* Complete history and physical exam, GOG performance status evaluation |
* Standard of care scans, which include staging CTs and/or PET scans, and MRI to verify eligibility and appropriate stage of disease. Blood tests will be done to check various organ functions. |
Treatment will be administered on an outpatient basis. |
The main difference between the proposed regimen in the trial and standard of care is as follows: |
1. The trial has a shortened course of EBRT. Standard of care utilizes 25 treatments, also known as "fractions" of EBRT, while the trial utilizes 8 fractions of EBRT. An equivalent "biological effective dose" is achieved by increasing the radiation dose per fraction. |
2. The concurrent cisplatin dosing is shortened from 5-6 cycles of cisplatin to 2 cycles of cisplatin. The dose of cisplatin is 40 mg/m2. |
This protocol requires photon IMRT technique followed by high dose rate (HDR) brachytherapy. The therapies use focused energy beams to kill cancer cells. Radiation therapy must be completed within 30 days +/- 2 days of initiation. Computed tomography simulation with the patient in a head-first laying on back-supine pos... |
IMRT will be given once daily Monday-Thursday, four fractions per week. The high-dose-rate (HDR) brachytherapy following institutional protocol. Brachytherapy will be delivered twice per week with a 2-day break in between sessions. A total of four brachytherapy treatments will be delivered. |
After active therapy is completed, treatment-related toxicity will be assessed at the 1-month post-treatment completion visit and again at the 3-month post-treatment completion. Patients removed from the study for unacceptable adverse events will be followed until resolution or stabilization of the adverse event(s). |
Routine MRI imaging to assess treatment response to radiotherapy is conducted at Day 15. Treatment response to radiotherapy followed by brachytherapy will be assessed at the 1- month and 3-months post-treatment completion. |
Following the 3-months post-treatment completion, study participants will be followed for disease progression and survival status until Year 2 post-treatment initiation. NOTE: Cervical cancer patients are routinely followed (clinical surveillance) every 3-months during the first two years post-treatment. conditions: Ut... |
<|newrecord|> nctId: NCT06331455 id: 23-5501 briefTitle: Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection acronym: SUPER overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2025-12 date: 2026-04 date: 2024-03-26 date: 2024-03-26 name:... |
Patients who are enrolled in this trial will receive combination of Non-ablative oligofractionated radiation (NORT) and two cycles of Durvalumab, an immunotherapy drug before their surgery. conditions: Lung Cancer Patients conditions: Non-small Cell Lung Cancer (NSCLC) studyType: INTERVENTIONAL phases: PHASE2 allocatio... |
<|newrecord|> nctId: NCT06331442 id: 006503905 briefTitle: The Effect of Photodynamic Therapy on Plaque in Orthodontic Patients overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2024-11 date: 2024-11 date: 2024-03-26 date: 2024-03-26 name: University of Zagreb class: OTHER briefSummary: This randomized controlled t... |
<|newrecord|> nctId: NCT06331429 id: EmoTiCare briefTitle: Emoticare: Serious Game for the Adaptation to the Disease of Adolescents With Type 1 Diabetes Mellitus. overallStatus: NOT_YET_RECRUITING date: 2024-08 date: 2024-09 date: 2025-02 date: 2024-03-26 date: 2024-03-28 name: University of Valencia class: OTHER name:... |
The platform integrates new technologies for assessment and intervention. Ecological Momentary Assessment enables real-time evaluation, with data transferred to the technological platform. Artificial intelligence personalizes interventions based on participants' socio-demographic characteristics and assessment results.... |
<|newrecord|> nctId: NCT06331416 id: 208_2022H briefTitle: One-device Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2026-04-01 date: 2026-09-30 date: 2024-03-26 date: 2024-03-26 name: University of Trieste... |
<|newrecord|> nctId: NCT06331403 id: 24-009 briefTitle: Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-04 date: 2025-04 date: 2024-03-26 date: 2024-03-26 name: Massachusetts General Hospital class: OTHER name: Harv... |
To inform plans for ongoing program refinement, the investigators will elicit specific feedback about study assessment tools, recruitment procedures, and group factors. Given the early-stage, open pilot nature of this protocol, the investigators will not set strict criteria to establish feasibility and acceptability bu... |
As a secondary aim, the investigators will explore the preliminary effects of the intervention on psychosocial measures of satisfaction with sexuality and impact of functional limitations, coping abilities, acceptance of body image changes, loneliness, and anticipated stigma. As noted above, the investigators will not ... |
In future, larger-scale, work, the investigators intend to conduct a larger randomized pilot trial to assess intervention acceptability, feasibility, as well as preliminary efficacy on essential outcomes related to sexual well-being. conditions: Colorectal Cancer conditions: Anal Cancer conditions: Sexual Dysfunction s... |
<|newrecord|> nctId: NCT06331390 id: 2181-198-03-04-24-0008 briefTitle: Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis overallStatus: RECRUITING date: 2024-04 date: 2024-06 date: 2024-07 date: 2024-03-26 date: 2024-03-26 name: University of Split, School of Medicine class: O... |
<|newrecord|> nctId: NCT06331377 id: 17-004541 id: NCI-2024-01765 type: REGISTRY domain: CTRP (Clinical Trial Reporting Program) id: 17-004541 type: OTHER domain: Mayo Clinic Institutional Review Board briefTitle: Clinical and Molecular Characteristics of Histiocytic Disorders overallStatus: RECRUITING date: 2017-07-27... |
<|newrecord|> nctId: NCT06331364 id: Pro00114347 id: R01AI168420 type: NIH link: https://reporter.nih.gov/quickSearch/R01AI168420 briefTitle: TREATment of Lower Respiratory Tract Infection in Sri Lanka (TREAT-SL) acronym: TREAT-SL overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-04 date: 2026-04 date: 2024-03... |
The primary objective of this trial is to determine the impact of an electronic clinical decision support tool (eCDST) on clinical outcomes and antibacterial prescription in subjects with LRTI in the intervention group compared to the control group. |
The study will enroll 765 patients ≥ 14 years of age. Medical wards will be randomized in clusters to the intervention at intervals of 3-6 months until all clusters cross over. Participants will be followed for 30 days from enrollment to record clinical outcomes and any antimicrobials prescribed. conditions: Lower Resp... |
This design combines elements of a cluster randomized trial (intervention is applied in clusters) and a before-after design (each cluster switches to intervention). All 9 pairs of wards (clusters) will start with an initial period of usual care. At intervals of 3-6 months (steps), a set of 3 pairs of wards (clusters) w... |
<|newrecord|> nctId: NCT06331351 id: A11203001 briefTitle: Effect of Jing Si Herbal Tea Liquid Packets on Chronic Pharyngolaryngitis overallStatus: RECRUITING date: 2024-02-22 date: 2025-10-31 date: 2025-12-31 date: 2024-03-26 date: 2024-03-26 name: Dalin Tzu Chi General Hospital class: OTHER briefSummary: Chronic phar... |
The investigators aimed to investigate the effect of Jing Si herbal tea liquid packets on chronic pharyngolaryngitis by a design of randomized, double-blind clinical trial in this study. The subjects who were bed-ridden, without self-care ability, receiving hemodialysis, no idea about the details of this study, poor co... |
A questionnaire for health and habits was performed at the start of the study, and a questionnaire for Reflux Symptom Index (RSI) was performed at the start and the end of the study. Finally, Student's t-test was used to test the difference between the Jing Si herbal tea group and the control group. And, multivariate l... |
<|newrecord|> nctId: NCT06331338 id: 202310085RIND briefTitle: Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes overallStatus: RECRUITING date: 2024-02-14 date: 2024-10-31 date: 2025-12-31 date: 2024-03-26 date: 2024-04-01 name: National Taiwan University Hospital class: OTHER ... |
<|newrecord|> nctId: NCT06331325 id: 724 briefTitle: Comparison of Frenotomy and Frenectomy Techniques for Management of High Frenum Attachment in Adults overallStatus: RECRUITING date: 2024-03-20 date: 2024-09-30 date: 2024-09-30 date: 2024-03-26 date: 2024-03-26 name: October University for Modern Sciences and Arts c... |
* Does Frenotomy procedure have a lower relapse rate compared to frenectomy? |
* Does Frenotomy procedure result in fewer postoperative complications? Participants will be divided into two groups. The intervention group will involve frenotomy procedure for participants and will be compared to the traditional frenectomy procedure in the comparator group. The level of the frenum will be measured at... |
<|newrecord|> nctId: NCT06331312 id: CAIN457C22301E1 id: 2023-508077-85-00 type: OTHER domain: EU CT number briefTitle: Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) acronym: REPLENISH-EXT overallStatus: RECRUITING date: 2024-04-10 date: 2028-03-13 date: 2028-05-08 date: 2024-03-26 d... |
<|newrecord|> nctId: NCT06331299 id: BL013 briefTitle: A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer acronym: UTOPIA overallStatus: NOT_YET_RECRUITING date: 2024-07 date: 2025-03 date: 2026-03 date: 2024-03-26 date: 2024-04-19 name: UroGen Pharm... |
<|newrecord|> nctId: NCT06331286 id: IIT20230091C-R1 briefTitle: The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity overallStatus: RECRUITING date: 2023-09-01 date: 2024-12-31 date: 2024-12-31 date: 2024-03-26 date: 2024-03-26 name: First Affiliated Hospital... |
<|newrecord|> nctId: NCT06331273 id: CT2024-ZJU-OBS3 briefTitle: Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2028-04-01 date: 2028-04-01 date: 2024-03-26 date: 2024-03-26 name: Zhejiang University class: OTH... |
<|newrecord|> nctId: NCT06331260 id: CT2024-ZJU-OBS2 briefTitle: Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2028-04-01 date: 2028-04-01 date: 2024-03-26 date: 2024-03-26 name: Zhejiang University ... |
<|newrecord|> nctId: NCT06331247 id: 20230520-2 briefTitle: MIND Diet to Improve Cognitive Function in Mild Stroke Patients (MINDICOMS) II overallStatus: RECRUITING date: 2024-03-18 date: 2025-12-31 date: 2025-12-31 date: 2024-03-26 date: 2024-04-04 name: Zhejiang University class: OTHER briefSummary: A 6-month pilot r... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.